BioTime Acquires Assets of Cell Targeting, Inc.
posted on January 28th, 2010
BioTime Acquires Assets of Cell Targeting, Inc. BioTime, Inc. (NYSE Amex:BTX) today announced that it has acquired substantially all the assets of Cell Targeting, Inc. (CTI), a Cleveland, Ohio-based biotechnology company conducting research in regenerative medicine. The technology acquired from CTI uses peptides selected for their ability to adhere to diseased tissues. By coating [...]